Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis

NCT05408910 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

NCT NCT05408910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05408910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 2/3
Overall status
Withdrawn
Start date
July 31, 2025
Completion date
September 30, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, cystic fibrosis, small bowel disease